Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01678482|
Recruitment Status : Completed
First Posted : September 5, 2012
Last Update Posted : September 5, 2012
This is a clinical research study to determine the ability of the Clear device to treat mild to moderate inflammatory acne, and to determine if the average person is able to use the device properly according to the labeling as describe in the operator manual.
The study involve treatments twice a week over 4 weeks total of 8 treatment sessions, in which the subjects will be treating themselves with the Clear device, and 2 follow-up visits to evaluate the results. The clinical result will be assessed by the investigator for improvement in the acne condition. Treatment will be performed on the face of subjects enrolled and who meet the inclusion criteria.
|Condition or disease||Intervention/treatment||Phase|
|Monitor Acne Lessions Count Reduction as Result of Usinfg the Device||Device: light based device for treatment of acne||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for the Treatment of Mild to Moderate Inflammatory Acne.|
|Study Start Date :||November 2011|
|Actual Primary Completion Date :||April 2012|
|Actual Study Completion Date :||April 2012|
Experimental: lession count reduction post treatment
Device: light based device for treatment of acne
- Acne lession count [ Time Frame: 3 months post treatment ]acne count post treatment compared to based line count
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678482
|Toronto, Ontario, Canada, M5R3N8|